Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33

Nanobodies (Nbs) are the smallest antigen-binding, single domain fragments derived from heavy-chain-only antibodies from Camelidae. Among the several advantages over conventional monoclonal antibodies, their small size (12−15 kDa) allows them to extravasate rapidly, to show improved tissue...

Full description

Saved in:
Bibliographic Details
Main Authors: Ema Romão, Ahmet Krasniqi, Laila Maes, Camille Vandenbrande, Yann G.-J. Sterckx, Benoit Stijlemans, Cécile Vincke, Nick Devoogdt, Serge Muyldermans
Format: Artigo
Language:Inglês
Published: MDPI AG 2020-01-01
Series:International Journal of Molecular Sciences
Subjects:
nanobody
cd33
acute myeloid leukemia
Online Access:https://www.mdpi.com/1422-0067/21/1/310
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items